Evidence map›Paper›PMID 38173597›Full record

ArticleRSC advances2024

Development of a green, concise synthesis of nicotinamide derivatives catalysed by Novozym® 435 from

Zhi-Kai Sheng, Yi Liu, Li-Hua Du, Shi-Yi Zhang, Ao-Ying Zhang, Han-Jia Xie, Hang Lin, Bing-Lin Yan, Miao-Miao Xue, Zhi-Xuan Ruan and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Zhi-Kai ShengCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.ORCID https://orcid.org/0009-0005-7531-3276
Yi LiuCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Li-Hua DuCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.ORCID https://orcid.org/0000-0001-6767-2248
Shi-Yi ZhangCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Ao-Ying ZhangCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Han-Jia XieCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Hang LinCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Bing-Lin YanCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Miao-Miao XueCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Zhi-Xuan RuanCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Guo-Neng FuCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Bing-Le PanCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Tong-Yao ZhouCollege of Pharmaceutical Science, ZheJiang University of Technology Zhejiang Hangzhou 310014 China orgdlh@zjut.edu.cn +86 571 88320903 +86-189-690-693-99.
Xi-Ping LuoZhejiang Provincial Key Laboratory of Chemical Utilization of Forestry Biomass, Zhejiang A&F University Zhejiang Hangzhou 311300 China.
Zhejiang University of Technology · CNZhejiang A & F University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing number of studies have shown that many nicotinamide derivatives exhibited extensive biological activities, such as anti-inflammatory and antitumor activity. In this paper, a green, concise synthesis of nicotinamide derivatives in sustainable continuous-flow microreactors catalysed by Novozym® 435 from

Identifiers

PMID38173597
PMCPMC10758761
OpenAlexW4390502301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.